The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 1.22

U.S. Complete Prevalence Counts, Invasive Cancers Only, January 1, 2016a
By Age at Prevalence

Site Sex Age at Prevalence
All Agesc Ages
0-9		 Ages
10-19		 Ages
20-29		 Ages
30-39		 Ages
40-49		 Ages
50-59		 Ages
60-69		 Ages
70+
All Sites Males 7,046,820 19,013 45,658 92,312 168,663 324,888 900,095 1,901,064 3,595,127
Females 8,292,168 17,282 38,768 93,009 252,052 631,369 1,452,263 2,179,010 3,628,415
Oral Cavity & Pharynx Males 250,059 79 483 1,435 3,554 12,626 49,283 84,123 98,476
Females 120,250 80 486 1,591 3,870 8,272 20,688 31,925 53,339
Esophagus Males 35,559 0 0 29 183 903 4,460 11,824 18,160
Females 10,918 0 0 11 54 242 1,320 3,146 6,144
Stomach Males 64,837 0 24 160 789 2,727 9,103 17,395 34,640
Females 48,217 0 34 215 859 2,676 7,066 11,599 25,768
Colon & Rectum Males 661,406 19 310 1,521 6,867 26,306 95,856 171,638 358,889
Females 663,516 39 358 1,832 6,831 25,137 85,953 146,080 397,285
Liver & Intrahepatic Bile Duct Males 57,099 624 769 529 434 1,690 10,569 26,699 15,787
Females 25,982 541 654 392 562 1,249 3,991 9,069 9,525
Pancreas Males 36,418 8 58 120 525 1,740 5,902 11,974 16,091
Females 37,136 12 70 338 716 2,183 6,294 10,710 16,812
Larynx Males 78,929 6 8 102 246 1,565 8,956 22,799 45,246
Females 17,422 0 16 16 151 658 3,099 5,295 8,188
Lung & Bronchus Males 239,856 51 127 370 1,223 4,483 23,185 66,309 144,108
Females 298,387 42 71 411 1,456 5,877 32,254 76,338 181,938
Melanoma of the Skin Males 611,158 58 530 4,277 16,027 39,516 98,628 166,460 285,663
Females 584,451 109 657 8,033 31,954 66,800 124,763 146,768 205,367
Breast Males 19,496 0 0 4 135 584 2,200 4,872 11,703
Females 3,477,866 16 25 3,276 39,571 207,774 602,250 975,728 1,649,227
Cervix Females 289,696 0 42 1,803 14,401 41,426 66,591 72,523 92,910
Corpus & Uterus, NOS Females 772,245 8 14 867 7,585 28,997 101,642 228,398 404,735
Ovaryd Females 229,875 106 1,124 4,479 8,509 19,167 46,532 64,680 85,279
Prostate Males 3,110,403 24 52 54 206 14,018 217,572 865,480 2,012,997
Urinary Bladder Males 525,713 60 99 541 2,145 8,784 39,848 120,226 354,010
Females 173,737 49 64 251 979 3,027 13,312 36,306 119,749
Kidney & Renal Pelvis Males 326,154 1,538 2,140 2,609 9,271 21,911 54,924 92,324 141,438
Females 207,050 1,706 2,575 3,132 6,768 14,900 33,535 52,972 91,463
Hodgkin Lymphoma Males 108,576 179 2,567 9,822 15,519 21,451 26,921 19,909 12,208
Females 102,397 70 1,843 8,849 16,460 21,101 24,748 17,379 11,947
Non-Hodgkin Lymphoma Males 367,558 900 4,029 8,311 13,996 27,628 61,422 94,982 156,290
Females 327,146 521 1,769 4,696 10,164 21,105 48,512 82,379 157,999
Myeloma Males 72,999 0 8 83 680 3,390 11,695 22,552 34,593
Females 58,392 3 9 60 426 2,610 8,912 17,672 28,699
Leukemia Males 235,556 6,996 15,050 16,790 12,272 17,182 30,974 51,848 84,446
Females 179,217 6,251 11,682 13,694 10,821 13,891 22,189 34,672 66,018
Acute Lymphocytic Leukemia Males 52,176 5,892 12,608 13,226 8,345 6,762 3,097 1,536 710
Females 43,589 5,242 9,971 10,290 7,475 5,610 2,594 1,532 874

Footnotes:

a U.S. 2016 cancer prevalence counts are based on 2016 cancer prevalence proportions from the SEER 13 areas not including the Alaska Natives Registry (San Francisco, Connecticut, Detroit, Hawaii, Iowa, New Mexico, Seattle, Utah, Atlanta, Rural Georgia, San Jose-Monterey, and Los Angeles) and 1/1/2016 U.S. population estimates based on the average of 2015 and 2016 population estimates from the U.S. Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 24 years.

b Cases diagnosed more than 24 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

c Due to rounding, the sum of the age specific estimates may not equal the all ages estimate.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.